Valantine Hannah sold BBIO
June 22, 2026 · Form 4 insider transaction
Valantine Hannah sold 2,808 shares of BridgeBio Pharma, Inc. at $68.00 per share, a transaction worth $190.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,808
Price
$68.00
Total value
$190.9K
InsiderValantine Hannah
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after11,455
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.